Acquisition Opportunity Health Catalyst acquired Carevive in June 2024, signaling a potential cross-sell path to Health Catalyst’s broader hospital and health system customers who may benefit from Carevive’s oncology-focused patient-reported outcomes and remote symptom monitoring capabilities.

Oncology Focus Carevive specializes in oncology patient experience and real-world data collection through ePROs, presenting a targeted upsell for cancer centers seeking to improve survival outcomes and quality of life, as well as data to inform cancer drug development.

Expansion Readiness Recent product enhancements and multilingual remote monitoring capabilities, including a Spanish version and native PROmpt app, indicate readiness for expansion into diverse patient populations and markets, including international or multi-site health systems.

Financial Leverage With reported revenue in the mid range of tens of millions and active growth funding, there is budgetary headroom for pilots or expanded deployments within mid-to-large health systems looking to deepen oncology patient engagement and outcome tracking.

Strategic Partnerships Carevive’s collaboration history with researchers (NCI Fast-Track awards) and Great Place to Work certification demonstrates potential for joint clinical studies, CMS/ payer collaborations, and value-based care initiatives that can be coordinated with prospective customers’ research and HR programs.